Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Formularies Will Offer Broad Coverage, Consultant Predicts

Executive Summary

Medicare prescription drug plans will cover most products once pricing stabilizes, Southeastern Consultants President Mary Kay Owens predicted during an Institute for International Research conference in Denver Sept. 21

You may also be interested in...



Reimportation Advocates Have Support Of “Rogue” Pfizer Exec

The pharmaceutical industry's experience with parallel trade in Europe demonstrates that safety concerns should not prevent Rx importation in the U.S., according to a Pfizer exec

Reimportation Advocates Have Support Of “Rogue” Pfizer Exec

The pharmaceutical industry's experience with parallel trade in Europe demonstrates that safety concerns should not prevent Rx importation in the U.S., according to a Pfizer exec

USP Drug Classification System Suggests At Least 348 Drugs On Formularies

The U.S. Pharmacopeia's draft model drug classification system for Medicare would require plans to cover at least 348 different drugs

Topics

UsernamePublicRestriction

Register

LL038093

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel